Mandate

Vinge advises Morrow Bank in connection with cross-border merger and list change from Oslo Børs to Nasdaq Stockholm

Vinge has advised Morrow Bank in connection with its reverse cross-border merger, whereby Morrow Bank AB is taking over Morrow Bank ASA. The Norwegian bank was previously listed on the Oslo Stock Exchange which was today transferred to Nasdaq Stockholm. Vinge has previously assisted Morrow Bank in obtaining a Swedish banking licence.

 The listing reflects the transformation we have executed over the past three years. We have built a scalable platform delivering efficiency, solid credit performance and earnings growth versus our Nordic consumer finance peers. Redomiciling to Sweden reduces capital requirements and levels the playing field, said Øyvind Oanes, CEO of Morrow Bank.

Vinge’s team consisted of Emma Stuart-Beck, Elias Bohlin, Henrik Schön, Caroline Krassén, David Flodin, Ebba Gäbel and Felicia Sandén (Financial Services), Rikard Lindahl, Joel Magnusson, Carl Lexenberg and Julia Jönsson (Corporate Public), as well as Siri Blomberg (IT&GDPR), Sam Seddigh, Alice Göransson and Louisa Fagarasan (Employment), Ian Jonsson and Filippa Eriksson (IP), Hedvig Ekdahl and Therese Baltzarsson (Commercial Agreements), Hedvig Merkel (Real Estate), Victor Ericsson, Maria Schultzberg and Vilma Henriksson (Tax), Diana Kanold and Alice Vångell (VDR).

Read the client's press release here and here.

Related

Vinge advises Sobro on its investment in Västkustens Konstruktionsbyrå

Västkustens Konstruktionsbyrå has decided to broaden its ownership structure by bringing in Sobro as a new co-partner and majority shareholder. The founders will remain with the company as the CEO and CTO respectively, and as significant shareholders. Västkustens Konstruktionsbyrå is an engineering consultancy company based in Gothenburg with cutting-edge expertise in project management, civil engineering and design.
April 23, 2026

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of SEK 350 million before transaction costs.
April 22, 2026

Vinge has advised Alder on the establishment of Alder Strategic Opportunities Fund I and on a fund credit facility agreement in connection with the fundraising

Vinge has advised Alder on the establishment of the continuation fund Alder Strategic Opportunities Fund I AB. In connection with the establishment, the fund acquires the portfolio companies SI and SMG from Alder II. Vinge also advised Alder on the entering into of a fund credit facility agreement with SEB.
April 20, 2026